Remove Genetic Analysis Remove Manufacturing Remove Reagent
article thumbnail

Agena Bioscience Granted EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel

The Pharma Data

.” With the panel’s authorization, Agena also aims to alleviate material shortages, enabling laboratories to accelerate testing without concerns about instrument or reagent availability. Agena Bioscience develops, manufactures, and supplies genetic analysis systems and reagents, including the MassARRAY ® System.

article thumbnail

Top 10 Biotech Trends for 2025

XTalks

Medical device manufacturers are leveraging these technologies to enhance their products, supporting healthcare providers and improving patient outcomes. NGS technology has revolutionized genetic analysis, enabling laboratories to rapidly sequence whole genomes, deeply sequence target regions and identify novel pathogens.